Birdwatch Note
2023-06-20 10:11:22 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Ivermectin was developed based on the research of Satoshi Omura, Distinguished Emeritus Professor of Kitasato University, who won the Nobel Prize in Physiology/ Medicine. The clinical trial by the university reports that it had no effect to new corona patients. https://www3.nhk.or.jp/news/html/20230524/amp/k10014077561000.html
Written by E06530D083F1C169D0BC97647834F1AC48D68F19A01D8D3831274E1A4495B2FC
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1670887947057627136
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1671098408617275393
- noteId - 1671098408617275393
- participantId -
- noteAuthorParticipantId - E06530D083F1C169D0BC97647834F1AC48D68F19A01D8D3831274E1A4495B2FC Participant Details
- createdAtMillis - 1687255882779
- tweetId - 1670887947057627136
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Ivermectin was developed based on the research of Satoshi Omura, Distinguished Emeritus Professor of Kitasato University, who won the Nobel Prize in Physiology/ Medicine. The clinical trial by the university reports that it had no effect to new corona patients. https://www3.nhk.or.jp/news/html/20230524/amp/k10014077561000.html
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-06-20 10:11:22 UTC (1687255882779) |
2023-06-20 17:40:51 UTC (1687282851573) |
CURRENTLY_RATED_NOT_HELPFUL | 2023-06-21 02:12:43 UTC (1687313563423) |
CURRENTLY_RATED_NOT_HELPFUL | 2023-06-20 17:40:51 UTC (1687282851573) |
CURRENTLY_RATED_NOT_HELPFUL |
Note Ratings
rated at | rated by | |
2023-06-20 13:42:26 -0500 | Rating Details | |
2023-06-20 12:25:35 -0500 | Rating Details | |
2023-06-20 12:13:25 -0500 | Rating Details | |
2023-06-20 12:07:59 -0500 | Rating Details | |
2023-06-20 11:43:50 -0500 | Rating Details | |
2023-06-20 11:41:37 -0500 | Rating Details | |
2023-06-20 11:25:17 -0500 | Rating Details | |
2023-06-20 11:16:25 -0500 | Rating Details | |
2023-06-20 11:08:50 -0500 | Rating Details | |
2023-06-20 10:53:37 -0500 | Rating Details | |
2023-06-20 10:48:58 -0500 | Rating Details | |
2023-06-20 10:43:55 -0500 | Rating Details | |
2023-06-20 10:38:41 -0500 | Rating Details | |
2023-06-20 10:32:45 -0500 | Rating Details | |
2023-06-20 10:31:15 -0500 | Rating Details | |
2023-06-20 10:20:08 -0500 | Rating Details | |
2023-06-20 10:14:10 -0500 | Rating Details | |
2023-06-20 09:05:56 -0500 | Rating Details | |
2023-06-20 08:46:57 -0500 | Rating Details | |
2023-06-20 08:39:44 -0500 | Rating Details | |
2023-06-20 08:09:13 -0500 | Rating Details | |
2023-06-20 07:54:55 -0500 | Rating Details | |
2023-06-20 07:48:41 -0500 | Rating Details | |
2023-06-20 07:21:13 -0500 | Rating Details | |
2023-06-20 06:50:05 -0500 | Rating Details | |
2023-06-20 06:39:34 -0500 | Rating Details | |
2023-06-20 06:37:19 -0500 | Rating Details | |
2023-06-20 06:37:11 -0500 | Rating Details | |
2023-06-20 06:23:15 -0500 | Rating Details | |
2023-06-20 06:17:09 -0500 | Rating Details | |
2023-06-20 06:09:40 -0500 | Rating Details | |
2023-06-20 06:04:11 -0500 | Rating Details | |
2023-06-20 05:28:54 -0500 | Rating Details |